Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Eye Cancer Companies

ID: MRFR/Pharma/3314-HCR
85 Pages
Vikita Thakur
Last Updated: May 15, 2026
Dedicated to ocular oncology, eye cancer companies focus on research, diagnostics, and treatments for ocular malignancies. These firms contribute to advancing the field of ophthalmic oncology, providing innovative solutions for the detection and management of eye cancers, ultimately improving patient outcomes and vision preservation.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Eye Cancer Market

Eye Cancer Key Companies
 
Latest Eye Cancer Companies Update

Roche partners with MacRegenics collaboration focuses on developing a novel gene therapy for choroidal melanoma, potentially offering a one-time curative treatment option.

Novartis collaborates with MeiraGTx partnership aims to develop a novel gene therapy for retinoblastoma, offering a non-invasive and potentially curative approach for children with this eye cancer.

List of Eye Cancer Key Companies in the Market

  • Novartis AG (Switzerland)
  • Spectrum Pharmaceuticals Inc. (U.S.)
  • GlaxoSmithKline Plc. (U.K.)
  • Bayer AG (Germany)
  • Amgen Inc. (U.S.)
  • Bristol-Myers Squibb Company (U.S.)
  • Eli Lilly and Company (U.S.)
  • AstraZeneca Plc. (U.K.)
  • Hoffmann-La Roche Ltd. (Switzerland)
  • Janssen Biotech Inc. (U.S.)
  • Sanofi (France)
  • AbbVie Inc. (U.S.)
  • Takeda Pharmaceuticals (Japan)
  • Pfizer Inc. (U.S.)
  • Merck & Co. Inc. (U.S.)
  • Oncomed Pharmaceuticals (U.S.)
  • Immunomedics (U.S.)